Internalization mechanisms of cell-penetrating peptides

Ivana Ruseska and Andreas Zimmer
Beilstein J. Nanotechnol. 2020, 11, 101–123. https://doi.org/10.3762/bjnano.11.10

Cite the Following Article

Internalization mechanisms of cell-penetrating peptides
Ivana Ruseska and Andreas Zimmer
Beilstein J. Nanotechnol. 2020, 11, 101–123. https://doi.org/10.3762/bjnano.11.10

How to Cite

Ruseska, I.; Zimmer, A. Beilstein J. Nanotechnol. 2020, 11, 101–123. doi:10.3762/bjnano.11.10

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 628.9 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Kalmouni, M.; Oh, Y.; Alata, W.; Magzoub, M. Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly. Pharmaceutics 2024, 16, 1443. doi:10.3390/pharmaceutics16111443
  • Nikitovic, D.; Kukovyakina, E.; Berdiaki, A.; Tzanakakis, A.; Luss, A.; Vlaskina, E.; Yagolovich, A.; Tsatsakis, A.; Kuskov, A. Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems. Cancers 2024, 16, 3768. doi:10.3390/cancers16223768
  • Kim, M. W.; Moon, S.; Park, Y. I.; Kim, J.; Kim, S. I.; Lee, R. Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer. Advanced Therapeutics 2024. doi:10.1002/adtp.202400248
  • Yi, Y.; Dai, L.; Lan, Y.; Tan, C.; Vázquez-Blomquist, D. M.; Zeng, G.; Jiang, D.; Yang, K.; Perea, S. E.; Perera, Y. CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling. Scientific reports 2024, 14, 26038. doi:10.1038/s41598-024-75990-1
  • Jourdain, M.-A.; Eyer, J. Recent advances in liposomes and peptide-based therapeutics for glioblastoma treatment. Journal of controlled release : official journal of the Controlled Release Society 2024, 376, 732–752. doi:10.1016/j.jconrel.2024.10.037
  • Choe, S. Insights into Translocation of Arginine-Rich Cell-Penetrating Peptides across a Model Membrane. The journal of physical chemistry. B 2024, 128, 10894–10903. doi:10.1021/acs.jpcb.4c04266
  • Pals, M. J.; Lindberg, A.; Velema, W. A. Chemical strategies for antisense antibiotics. Chemical Society reviews 2024. doi:10.1039/d4cs00238e
  • Stepanichev, M. Y.; Onufriev, M. V.; Moiseeva, Y. V.; Nedogreeva, O. A.; Novikova, M. R.; Kostryukov, P. A.; Lazareva, N. A.; Manolova, A. O.; Mamedova, D. I.; Ovchinnikova, V. O.; Kastberger, B.; Winter, S.; Gulyaeva, N. V. N-Pep-Zn Improves Cognitive Functions and Acute Stress Response Affected by Chronic Social Isolation in Aged Spontaneously Hypertensive Rats (SHRs). Biomedicines 2024, 12, 2261. doi:10.3390/biomedicines12102261
  • de Morais, C. C. P. d. L.; Correia, E. M.; Bonamino, M. H.; Vasconcelos, Z. F. M. d. Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy. Human gene therapy 2024, 35, 781–797. doi:10.1089/hum.2024.020
  • Zaman, R.; Chowdhury, E. H. Therapeutic peptides targeting intracellular molecules. European Polymer Journal 2024, 219, 113386. doi:10.1016/j.eurpolymj.2024.113386
  • Ardila-Chantré, N.; Parra-Giraldo, C. M.; Vargas-Casanova, Y.; Barragán-Cardenas, A. C.; Fierro-Medina, R.; Rivera-Monroy, Z. J.; Rivera-Monroy, J. E.; García-Castañeda, J. E. Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro. Exploration of Drug Science 2024, 614–631. doi:10.37349/eds.2024.00064
  • Maani, Z.; Rahbarnia, L.; Bahadori, A.; Chollou, K. M.; Farajnia, S. Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery. Drug discovery today 2024, 29, 104191. doi:10.1016/j.drudis.2024.104191
  • Beribisky, A. V.; Huber, A.; Sarne, V.; Spittler, A.; Sukhbaatar, N.; Seipel, T.; Laccone, F.; Steinkellner, H. MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities. Protein science : a publication of the Protein Society 2024, 33, e5170. doi:10.1002/pro.5170
  • Udabe, J.; Muñoz‐Juan, A.; Tafech, B.; Orellano, M. S.; Hedtrich, S.; Laromaine, A.; Calderón, M. Modulating the Mucosal Drug Delivery Efficiency of Polymeric Nanogels Tuning their Redox Response and Surface Charge. Advanced Functional Materials 2024, 34. doi:10.1002/adfm.202407044
  • Polderdijk, S. G. I.; Limzerwala, J. F.; Spiess, C. Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides. PloS one 2024, 19, e0305848. doi:10.1371/journal.pone.0305848
  • Wang, H.; Zheng, M.; Chen, Y.; Cheng, L.; Qi, X.; Yu, H.; Sun, J.; Liu, J.; Wang, R.; Hu, Y.; Lin, T.; Zhang, Y.; Xu, W.; Wang, T.; Wang, Z.; Yao, J.; Huang, P.; Ran, H. Macrophage-Targeted multifunctional nanoparticles for detection and treatment of intraplaque hemorrhage. Chemical Engineering Journal 2024, 496, 153722. doi:10.1016/j.cej.2024.153722
  • Yi, X.; Hussain, I.; Zhang, P.; Xiao, C. Nuclear-Targeting Peptides for Cancer Therapy. Chembiochem : a European journal of chemical biology 2024, e202400596. doi:10.1002/cbic.202400596
  • Lopuszynski, J.; Wang, J.; Zahid, M. Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides. Molecules (Basel, Switzerland) 2024, 29, 4088. doi:10.3390/molecules29174088
  • Mai, L. D.; Wimberley, S. C.; Champion, J. A. Intracellular delivery strategies using membrane-interacting peptides and proteins. Nanoscale 2024, 16, 15465–15480. doi:10.1039/d4nr02093f
  • Durak, S.; Sutova, H. E.; Ceylan, R.; Aciksari, A.; Yetisgin, A. A.; Onder Tokuc, E.; Kutlu, O.; Karabas, V. L.; Cetinel, S. A Nanogel Formulation of Anti-VEGF Peptide for Ocular Neovascularization Treatment. ACS applied bio materials 2024, 7, 6001–6013. doi:10.1021/acsabm.4c00585

Patents

  • SAITAKIS MICHAEL; AMIGORENA SEBASTIAN; FUENTEALBA JAIME RODRIGO; LOPEZ COBO SHEILA; ALCANTARA MARION; TSALKITZI KYRIAKI. COMPOSITIONS AND METHODS FOR TREATING A REFRACTORY OR RELAPSED CANCER OR A CHRONIC INFECTIOUS DISEASE. WO 2023222928 A2, Nov 23, 2023.
  • BLACKWOOD ERIK; GLEMBOTSKI CHRISTOPHER. SGK1 INHIBITORY COMPOSITIONS AND METHODS. WO 2023114714 A1, June 22, 2023.
Other Beilstein-Institut Open Science Activities